Smart science to improve lives™
analytical purity chromatography image
monoclonal antibody image
Croda pharma employee in a lab
vaccine development
Main image used for Virodex

Empowering biologics delivery

Unlocking future therapies

We're enabling drug delivery through high purity excipients and next generation lipids and adjuvants to tackle your solubility and stability challenges

We're developing the next generation of excipients for human and veterinary applications

Looking for something in particular? Search our broad portfolio here: 

Image of croda employee in lab

Products formulators love

We’re committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.

Formulate the future with Croda Pharma. Unlock sustainable ingredients for vaccines

Explore by market:

scientist in lab looking at a slide

Human and veterinary pharmaceuticals

Our purpose, Smart science to improve lives™, is at the core of our human and veterinary market strategy. We support the pharmaceutical market by developing high purity excipients which enhance delivery, efficacy, and stability of actives. We also manufacture industry leading high purity vaccine adjuvants and innovative lipids.
Take me there
pharmacist and consumer looking at offering in a pharmacy

Consumer Health

Explore our excipients for the Consumer Health market that will aid in developing innovative products to meet changing consumer needs and market trends. Learn how we can help you grow your product brand by offering quality specialty ingredients developed for the OTC, oral hygiene, and human nutrition markets.
Take me there

Decades of driving biopharma forward

image of covid vaccine icon
1st supplier of lipids for COVID-19 mRNA vaccine View
winners trophy icon image
Winner of Best Supplier for COVID-19 Vaccine Development 2022 View
icon used to represent a gene
Customising lipids since 1950 View
Image of Steve Rumbelow in the lab

Smart science to improve lives™

Your pharma solutions partner:

  • High purity excipients: Optimising the performance of formulations to solve your stability and solubility challenges
  • Vaccine adjuvants: Committed to the highest standards, with 80+ years of expertise in adjuvant research and development
  • Innovative lipids: Enabling the delivery and stability of nucleic acid-based vaccines, therapeutics and gene editing technology. 

We are committed to enabling the next generation of drug delivery systems, so by partnering with Croda Pharma, you are in safe hands.


Your pharma solutions partner

circular icon of a chemical manufacturing plant

Unparalleled purity excipients

Tackle your stability challenges with unparalleled excipients of purity tailored to your needs, across all administration routes
image in circle of people working in a lab

Formulate and troubleshoot faster

Create tailored excipient solutions by working directly in partnership with our scientists to accelerate your development timelines

Regulatory expertise

Our regulatory and quality specialists are practised in supporting the use of novel and innovative excipients in a variety of formulations
Learn more about us

The race to beat COVID-19

As COVID-19 surged across the world, our team fought against time to get critical materials ready for the worlds leading vaccines.

Watch the story unfold in our mini documentary.

Read about our latest investments in vaccines
Get exclusive access to Croda Pharmas mailing list. Gain exclusive access to new excipients and hear direct from the experts on how to improve formulations.

View our most recent blogs:

Filter by

Kritika Bajaj, Croda Pharma

Spotlight on Kritika Bajaj

Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...

Read more
test tube and flask in medical chemistry

Croda’s response to Sustainable Markets Initiative for supplier sustainability targets

The recent open letter from the Sustainable Markets Initiative Health Systems Task Force called for Healthcare supply chains to become greener, more efficient and circular and set out a series of...

Read more
Vaccine shown over map image

Sustainability for vaccines: Decarbonisation of one of our key sites

Sustainability is often defined as meeting the needs of those alive today without compromising the ability of future generations to meet their needs. It is a long-term goal that covers three pillars:...

Read more
lipid nanoparticle cross section

A powerful match - celebrating three years of Croda Pharma and Avanti

Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...

Read more